Austin, Texas, April 9, 2026 /PRNewswire/ — L7 Informatics today announced L7|Synapse™an agent AI layer built on the L7|ESP platform, designed to ensure reliable and secure artificial intelligence operations in regulated life sciences environments.
Across industries, organizations are under pressure to accelerate throughput while maintaining rigorous quality and compliance standards. According to McKinsey & Company, advanced analytics and automation can improve productivity in pharmaceutical operations by up to 30%, but adoption remains uneven due to fragmented data and workflows. Similarly, Deloitte reports that more than 60% of life sciences companies continue to suffer from siled systems that limit the effective use of data. Meanwhile, Gartner notes that less than half of AI initiatives in regulated industries successfully scale beyond the pilot stage.
L7|SYNAPSE addresses this gap by embedding a conversational, context-aware interface directly into the workflow execution layer of L7|ESP. Users can use natural language (including voice) to build agents, ask questions, retrieve data, generate workflows, and create summaries without having to navigate the underlying systems or data structures. More importantly, all responses are based on an organization-specific, private knowledge base that includes SOPs, protocols, and batch records, ensuring output is accurate, traceable, and consistent with controlled data.
The development of L7|SYNAPSE has been shaped by close collaboration with early customers, incorporating real-world feedback from laboratory, quality, and manufacturing environments. These insights directly impact key capabilities, from knowledge bases and privilege-awareness to workflow generation and cross-system data access, ensuring solutions address the practical challenges encountered in daily work.
By retrieving relevant information before invoking large-scale language models, L7|SYNAPSE provides real-time operational context and citation-backed answers that reflect user privileges. This approach allows organizations to move beyond experimental or specific AI use cases toward consistent, compliant execution at scale. The platform also supports flexible integration with all major cloud-based (Claude, ChatGPT, AWS Bedrock) or locally hosted LLM models, allowing organizations to meet security and regulatory requirements. L7|SYNAPSE is also compliant with industry standards such as MCP and A2A.
“L7|SYNAPSE is designed to bridge the gap between the capabilities of AI and the operational realities of regulated scientific enterprises large and small,” said Dr. Vasu Rangadass, President and CEO of L7 Informatics. “This enables teams to navigate complex workflows in a simpler way, ensuring that all actions and insights are based on trusted, managed data.”
L7|SYNAPSE streamlines workflows across laboratory, quality, manufacturing operations, and technology transfer between pharmaceutical companies and CRDMOs by reducing the need to search across systems, interpret fragmented documents, or rely on specialized knowledge. The result is faster decision-making, greater consistency, and a more scalable execution approach across the scientific value chain.
Learn more about L7|SYNAPSE here.
https://l7informatics.com/l7synapse
Contact L7 Informatics:
https://l7informatics.com/get-started/
About L7 Informatics
L7 Informatics provides scientific data management and workflow orchestration solutions that unify data, processes, and insights across life sciences organizations, enabling rapid innovation with built-in compliance.
Source L7 Informatics
